Centers | ||
|
|
|
Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | Therapeutic Accelerator Program (TAP) | Edinburgh Drug Discovery |
Chulalongkorn
Drug Discovery and Drug Development Research Center (Chula4DR) was
established in 2017, with the aim to facilitate advancement of academic
drug discovery and drug development research by leveraging innovations
and sciences... Read more |
Test |
Based within the world-leading University of Edinburgh Medical School, Edinburgh Drug Discovery has a track record in successfully translating drug discovery projects from target identification through to clinical evaluation. Key areas of... |
Partnerships |
Events |
Jobs |
Sanofi and Joslin Diabetes Center to Develop New Drugs for Diabetic CareJoslin Diabetes Center a teaching and research affiliate of Harvard Medical School and Sanofi have entered into a partnership agreement to develop new drugs to treat diabetes. Under this collaboration, Sanofi will have the right to commercialize... View all Johnson & Johnson to Support Pain Research at Queensland UniversityJohnson & Johnson and Institute for Molecular Bioscience (IMB) at University of Queensland have entered into research agreement to develop peptides using IMB's novel assay to treat chronic pain. Johnson & Johnson and its affiliates will provide... View all Sanford-Burnham Partners with Johnson and Johnson to Identify New Treatments for Neurological DisordersSanford-Burnham Medical Institute and Janssen a unit of Johnson and Johnson have entered into research and development partnership to identify novel targets and develop drugs to treat Alzheimer's disease and psychiatric disorders. This multi year... View all |
No EVENTS for listing |
No Job Posts |
